ALPMY Stock Astellas Pharma (ALPMY, $9.82) was a top winner yesterday, jumping +3.26%

GET DAILY SIGNALS

Get AI intraday signals

ALPMY - Astellas Pharma, Inc.

Loading...

Price: $9.82

Daily change: +$0.31 (+3.26%)

Daily volume: 1.1M

Capitalization: $17.5B

Industry: Pharmaceuticals: Major

Astellas Pharma (ALPMY, $9.82) was one of the top gainers yesterday, rising to $9.82 per share. A.I.dvisor analyzed 58 stocks in the Pharmaceuticals: Major Industry and found that of them (7) are in an Uptrend while of them (2) are in a Downtrend.

ALPMY sees MACD Histogram just turned negative

ALPMY saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on January 20, 2026. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 43 instances where the indicator turned negative. In of the 43 cases the stock moved lower in the days that followed. This puts the odds of a downward move at .

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for ALPMY moved out of overbought territory on January 15, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 23 similar instances where the indicator moved out of overbought territory. In of the 23 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ALPMY declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

ALPMY broke above its upper Bollinger Band on January 07, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 3 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

The Momentum Indicator moved above the 0 level on February 03, 2026. You may want to consider a long position or call options on ALPMY as a result. In of 75 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ALPMY advanced for three days, in of 300 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 196 cases where ALPMY Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.436) is normal, around the industry mean (9.409). P/E Ratio (31.556) is within average values for comparable stocks, (24.389). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.865). Dividend Yield (0.036) settles around the average of (0.025) among similar stocks. P/S Ratio (1.964) is also within normal values, averaging (3.952).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ALPMY’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ALPMY’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 72, placing this stock worse than average.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.